Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2014Journal of Lipid ResearchOpen Access

Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin

View Full Paper
Ask AI
Bookmark
Share

Authors

SKSusan KühnastNetherlands Organisation for Applied Scientific ResearchJHJosé W.A. van der HoornLibra Revalidatie & AudiologieEPElsbet PietermanNetherlands Organisation for Applied Scientific Research

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kühnast et al. (2014) studied this question.

synapsesocial.com/papers/6a7cb3ff398814c3397ccf68https://doi.org/10.1194/jlr.m051326
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy2013 · 1,277 citations
  2. 2Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin2011 · 34 citations
  3. 3Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia2012 · 470 citations
  4. 4Torcetrapib Does Not Reduce Atherosclerosis Beyond Atorvastatin and Induces More Proinflammatory Lesions Than Atorvastatin2008 · 96 citations
  5. 5Decreased plasma cholesterol and hypersensitivity to statins in mice lacking <i>Pcsk9</i>2005 · 686 citations